Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraosseous Morphine in ACL Reconstruction
NCT06511232Phase 4Recruiting
- Sponsor
- Houston Methodist Research Institute
- Start
- Aug 2024
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative pain comparing Intraosseous Injection of Morphine with Standard of Care Morphine Administration (2 arms). Primary endpoints: Patient Pain Levels in the Post-Operative Period as assessed by a patient-reported post operative symptom journal at 12 weeks, Changes in Post-Operative Opioid Use at 2 weeks and 1 more. Started Aug 2024; status: recruiting.
02
Drugs
morphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06511232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06511232.